Literature DB >> 17603540

Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer.

Anna Rodina1, Maria Vilenchik, Kamalika Moulick, Julia Aguirre, Joungnam Kim, Anne Chiang, Julie Litz, Cristina C Clement, Yanlong Kang, Yuhong She, Nian Wu, Sara Felts, Peter Wipf, Joan Massague, Xuejun Jiang, Jeffrey L Brodsky, Geoffrey W Krystal, Gabriela Chiosis.   

Abstract

The heat shock protein 90 (Hsp90) has a critical role in malignant transformation. Whereas its ability to maintain the functional conformations of mutant and aberrant oncoproteins is established, a transformation-specific regulation of the antiapoptotic phenotype by Hsp90 is poorly understood. By using selective compounds, we have discovered that small-cell lung carcinoma is a distinctive cellular system in which apoptosis is mainly regulated by Hsp90. Unlike the well-characterized antiapoptotic chaperone Hsp70, Hsp90 is not a general inhibitor of apoptosis, but it assumes this role in systems such as small-cell lung carcinoma, in which apoptosis is uniquely dependent on and effected through the intrinsic pathway, without involvement of caspase elements upstream of mitochondria or alternate pathways that are not apoptosome-channeled. These results provide important evidence for a transformation-specific interplay between chaperones in regulating apoptosis in malignant cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17603540     DOI: 10.1038/nchembio.2007.10

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  69 in total

1.  Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment.

Authors:  Hardik J Patel; Shanu Modi; Gabriela Chiosis; Tony Taldone
Journal:  Expert Opin Drug Discov       Date:  2011-05       Impact factor: 6.098

2.  Paralog-selective Hsp90 inhibitors define tumor-specific regulation of HER2.

Authors:  Pallav D Patel; Pengrong Yan; Paul M Seidler; Hardik J Patel; Weilin Sun; Chenghua Yang; Nanette S Que; Tony Taldone; Paola Finotti; Ralph A Stephani; Daniel T Gewirth; Gabriela Chiosis
Journal:  Nat Chem Biol       Date:  2013-09-01       Impact factor: 15.040

Review 3.  Heat shock protein 70 (hsp70) as an emerging drug target.

Authors:  Christopher G Evans; Lyra Chang; Jason E Gestwicki
Journal:  J Med Chem       Date:  2010-06-24       Impact factor: 7.446

4.  IP6K2 is a client for HSP90 and a target for cancer therapeutics development.

Authors:  David S Shames; John D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-29       Impact factor: 11.205

5.  A precursor-specific role for Hsp40/Hsc70 during tail-anchored protein integration at the endoplasmic reticulum.

Authors:  Catherine Rabu; Peter Wipf; Jeffrey L Brodsky; Stephen High
Journal:  J Biol Chem       Date:  2008-07-29       Impact factor: 5.157

6.  Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Authors:  Hardik J Patel; Pallav D Patel; Stefan O Ochiana; Pengrong Yan; Weilin Sun; Maulik R Patel; Smit K Shah; Elisa Tramentozzi; James Brooks; Alexander Bolaender; Liza Shrestha; Ralph Stephani; Paola Finotti; Cynthia Leifer; Zihai Li; Daniel T Gewirth; Tony Taldone; Gabriela Chiosis
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

Review 7.  New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential.

Authors:  Yanyan Li; Tao Zhang; Steven J Schwartz; Duxin Sun
Journal:  Drug Resist Updat       Date:  2009 Feb-Apr       Impact factor: 18.500

8.  Mutations in the Yeast Hsp70, Ssa1, at P417 Alter ATP Cycling, Interdomain Coupling, and Specific Chaperone Functions.

Authors:  Patrick G Needham; Hardik J Patel; Gabriela Chiosis; Patrick H Thibodeau; Jeffrey L Brodsky
Journal:  J Mol Biol       Date:  2015-04-23       Impact factor: 5.469

Review 9.  Recent progress in asymmetric Biginelli reaction.

Authors:  Majid M Heravi; Shima Asadi; Boshra Malekzadeh Lashkariani
Journal:  Mol Divers       Date:  2013-04-16       Impact factor: 2.943

10.  Association of hsp90 to the hTERT promoter is necessary for hTERT expression in human oral cancer cells.

Authors:  Reuben H Kim; Roy Kim; Wei Chen; Shen Hu; Ki-Hyuk Shin; No-Hee Park; Mo K Kang
Journal:  Carcinogenesis       Date:  2008-09-26       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.